Trademark: 87069542
Status Date
Tuesday, December 12, 2023
Registration Number
5287408
Registration Date
Tuesday, September 12, 2017
Filing Date
Monday, June 13, 2016
Published for Opposition
Tuesday, November 22, 2016
5 Medicinal preparations for photosensitizing agents used as a dermatologic drug or prodrug for the treatment of skin cancer by phototherapy; Chemical reagents for medical and veterinarian use; Chemical reagents for cultures of microorganisms for medical use, namely, in culture media for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Chemical preparations for medical purposes, namely, for immunology research; Organic chemical preparations for medical purposes, namely, immunomodulatory compounds with anti-inflammatory properties; Organic chemical preparations for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, used as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA); Medical enzyme
Dec 12, 2023
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Dec 12, 2023
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Dec 12, 2023
Case Assigned To Post Registration Paralegal
Jun 14, 2023
Teas Section 8 & 15 Received
Sep 12, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Aug 18, 2022
Teas Change Of Correspondence Received
Aug 18, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 18, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 12, 2017
Registered-Principal Register
Aug 10, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 9, 2017
Allowed Principal Register - Sou Accepted
Aug 9, 2017
Statement Of Use Processing Complete
Jul 11, 2017
Use Amendment Filed
Aug 5, 2017
Case Assigned To Intent To Use Paralegal
Jul 11, 2017
Teas Statement Of Use Received
Jul 11, 2017
Teas Change Of Correspondence Received
Jan 17, 2017
Noa E-Mailed - Sou Required From Applicant
Nov 22, 2016
Official Gazette Publication Confirmation E-Mailed
Nov 22, 2016
Published For Opposition
Nov 2, 2016
Notification Of Notice Of Publication E-Mailed
Oct 18, 2016
Law Office Publication Review Completed
Oct 17, 2016
Assigned To Lie
Sep 30, 2016
Approved For Pub - Principal Register
Sep 27, 2016
Examiner's Amendment Entered
Sep 27, 2016
Notification Of Examiners Amendment E-Mailed
Sep 27, 2016
Examiners Amendment E-Mailed
Sep 27, 2016
Examiners Amendment -Written
Sep 22, 2016
Assigned To Examiner
Jun 20, 2016
New Application Office Supplied Data Entered
Jun 16, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
